Besides, peroxiredoxin IV; is considered to have the ability to fight against diabetes mellitus, atherosclerosis, insulin resistance, and nonalcoholic fatty liver diseases by suppressing oxidative damage, inflammatory cytokines, and apoptotic activities [31–33]. Here, PRDX4 is linked to metabolic dysfunction-associated steatotic liver disease.